Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00054886 · ClinicalTrials.gov registry record · Phase 2
Study of the Safety and Efficacy of SU-011,248 in Adult Patients With Advanced Kidney Cancer
A Phase 2 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 2
- Development phase
- 63
- Enrollment target
NCT00054886 is a Phase 2 study that has completed, run by Pfizer. The registered enrollment target is 63 participants.
The verdict
NCT00054886, a Phase 2 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 63 participants
- Enrollment target
Study Summary
The primary goal of the study is to evaluate the effectiveness and safety of SU-011,248 as a treatment for metastatic kidney cancer.
Interventions
- DRUG SU-011,248
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2003-01 |
| Est. Completion | 2004-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00054886
The ClinicalTrials.gov registry entry for NCT00054886 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SU-011,248 is the first listed.
NCT00054886 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00054886 about?
NCT00054886 is a clinical study titled "Study of the Safety and Efficacy of SU-011,248 in Adult Patients With Advanced Kidney Cancer". The primary goal of the study is to evaluate the effectiveness and safety of SU-011,248 as a treatment for metastatic kidney cancer.
What is the current status of trial NCT00054886?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 63 participants. The study started on 2003-01. Estimated completion is 2004-08.
What interventions are being tested in trial NCT00054886?
The interventions under investigation include: SU-011,248 (DRUG).
Who is sponsoring clinical trial NCT00054886?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.